• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>India Fund

India Fund

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in ...

    A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment History

  2. Commodities CEFs Tank in September

    The Bond King's departure had a small impact on CEF performance compared with the onslaught in the commodities market.

  3. Optimism in India

    Appears to be priced in, for now.

  4. What the Big Guys Are Buying (and Selling)

    A look at ownership data can provide a more detailed look at what mutual funds and institutional players are buying and selling. 

  5. 2011 Closed-End Funds Year in Review

    Despite the market's wild ride, most CEFs closed the year with positive share price and NAV returns. 

  6. For Closed-End Funds, Cheaper Isn't Necessarily Better

    When it comes to expenses, CEFs are quite different than open-end mutual funds.

  7. Equity Fund Launches Are Surprisingly Common Despite Outflows

    We saw some big trend reversals in 2012's fund launches.

  8. Getting Creative With Foreign-Focused CEFs

    Morningstar's Steve Pikelny discusses his closed-end fund ideas for international fixed-income and equity exposure and the advantages for using CEFs in these areas.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.